A case of acute myocardial infarction in a patient with essential thrombocythaemia treated with anagrelide

A case of acute myocardial infarction in a patient with essential thrombocythaemia treated with anagrelide

Anagrelide is a medication primarily used to manage thrombocytosis, an abnormal increase in platelet levels in the blood. It is often prescribed for patients with myeloproliferative disorders, such as essential thrombocythaemia (ET). Given the heightened susceptibility to thromboembolism associated...

Full description

Bibliographic Details
Main Authors:	Ekrem Yetiskul, Aqsa Nisar, Salman Khan, Faris Qaqish, Danyal Khan, Alexander Bershadskiy
Format:	Article
Language:	English
Published:	SMC MEDIA SRL 2024-02-01
Series:	European Journal of Case Reports in Internal Medicine
Subjects:	essential thrombocythaemia anagrelide myocardial infarction thrombosis
Online Access:	https://www.ejcrim.com/index.php/EJCRIM/article/view/4340

Similar Items

The role of anagrelide in the treatment of essential thrombocytaemia
by: Giuseppe Civardi, et al.
Published: (2013-05-01)

Leg Ulcers Associated with Anagrelide
by: Tuba Oskay, et al.
Published: (2021-12-01)

Essential thrombocythaemia as a causative agent of portal vein thrombosis: A case report
by: Ćulafić Đorđe, et al.
Published: (2009-01-01)

Anagrelide‐induced pericardial effusion in a patient with essential thrombocythemia
by: David Song, et al.
Published: (2023-04-01)

Anagrelide is an anti-megakaryocytic and not an anti-platelet agent
by: Steve P. Watson, et al.
Published: (2019-01-01)

Essential thrombocythaemia in a child of three years
by: R.M. Espinosa-Elizondo, et al.
Published: (2015-07-01)

Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)
by: Jumoke Okikiolu, et al.
Published: (2023-01-01)

Skin cancer in essential thrombocythaemia and polycythaemia vera patients treated with hydroxycarbamide
by: Abhinav Mathur, et al.
Published: (2022-11-01)

A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatment
by: Ja Min Byun, et al.
Published: (2022-11-01)

The different variant allele frequencies of type I/type II mutations and the distinct molecular landscapes in CALR-mutant essential thrombocythaemia and primary myelofibrosis
by: Yuxia Pan, et al.
Published: (2022-12-01)

Longitudinal trends of peripheral blood counts in polycythaemia vera and essential thrombocythemia patients in the UK
by: Lewis Carpenter, et al.
Published: (2022-08-01)

Cecal cancer with essential thrombocythemia treated by laparoscopic ileocecal resection: a case report
by: Masaya Hiyoshi, et al.
Published: (2019-06-01)

Acute myocardial infarction in an untreated patient with acute myeloid leukemia
by: Doreen Kamoga, et al.
Published: (2024-03-01)

Disease progression in patients with essential thrombocythaemia receiving anagrelide within a single institution
by: Gray, N, et al.
Published: (2020)

Prognosing of myocardial infarction outcome in arterial hypertension patients
by: V. N. Ardashev, et al.
Published: (2004-04-01)

Case Report: A Rare Case of Acute Anterior Myocardial Infarction Simultaneously Associated With Aortic Mural Thrombosis Due to Essential Thrombocytosis
by: Sheng Ye, et al.
Published: (2022-02-01)

Determinants of Endogenous Fibrinolysis in Whole Blood Under High Shear in Patients With Myocardial Infarction
by: Rahim Kanji, MB, BS, et al.
Published: (2022-11-01)

Is It Possible to Predict Clonal Thrombocytosis in Triple-Negative Patients with Isolated Thrombocytosis Based Only on Clinical or Blood Findings?
by: Tanja Belčič Mikič, et al.
Published: (2021-12-01)

Long-term clinical outcomes of the left ventricular thrombus in patients with ST elevation anterior myocardial infarction
by: Mahmoud Ebrahimi, et al.
Published: (2015-01-01)

Incidence, Predictors and Outcomes of Subacute Stent Thrombosis following Primary Stenting for ST-elevation Myocardial Infarction
by: Su-Kiat Chua, et al.
Published: (2010-06-01)

Coronary clot composition after myocardial infarction: Thrombus age matters
by: Anke C. Fender, et al.
Published: (2020-02-01)

Unmet Needs in Managing Myocardial Infarction in Patients With Malignancy
by: Taku Inohara, et al.
Published: (2019-05-01)

Is Endogenous Fibrinolysis a Major Player in Occurrence of Atherothrombotic Events Following Acute Myocardial Infarction?∗
by: Min Gyu Kang, MD, PhD, et al.
Published: (2022-11-01)

Characteristics and Outcomes of Early Recurrent Myocardial Infarction After Acute Myocardial Infarction
by: Raunak Nair, et al.
Published: (2021-08-01)

Left Ventricular Thrombosis in a Case of Acute Inferior Wall Myocardial Infarction
by: Anil Kumar Singhi, et al.
Published: (2021-01-01)

Morphological and Immunohystochemical Characteristics of Aspirated Thrombi in Patients with ST-Elevation Myocardial Infarction
by: H S Sisakian, et al.
Published: (2019-09-01)

Are patients with high-risk polycythemia vera receiving cytoreductive medications? A retrospective analysis of real-world data
by: Dilan Paranagama, et al.
Published: (2018-07-01)

Comparison of Short Term In-Hospital Outcomes in patients presenting with ST-Elevation Myocardial Infarction Versus Non-ST-Elevation Myocardial Infarction
by: Masood Khan, et al.
Published: (2023-12-01)

Individual acute-phase bleeding and thrombotic risk balance assessment in patients undergoing percutaneous coronary intervention for acute myocardial infarction
by: Yohei Sotomi, et al.
Published: (2023-04-01)

Acute myocardial infarction and transient elevated anticardiolipin antibody in a young adult with possible familial hypercholesterolemia: a case report
by: Xin Su, et al.
Published: (2019-06-01)

The Association between Vitamin D Levels and Thrombus Burden in Patients with ST-Elevation Myocardial Infarction
by: Faysal Şaylık, et al.
Published: (2022-04-01)

Hypercoagulability and the risk of recurrence in young women with myocardial infarction or ischaemic stroke: a cohort study
by: Alberto Maino, et al.
Published: (2019-03-01)

The value of routine blood test parameters obtained at admission to predict acute stent thrombosis in patients with st-segment elevation myocardial infarction
by: Yusuf Cekici
Published: (2020-12-01)

Simultaneous Inhibition of Thrombosis and Inflammation Is Beneficial in Treating Acute Myocardial Infarction
by: Ian Vargas, et al.
Published: (2023-04-01)

Significance of C-Reactive Protein in Patients with ST-Elevation Myocardial Infarction Over Non-ST-Elevation Myocardial Infarction
by: Shahzadi Anum, et al.
Published: (2023-01-01)

Thrombus formation in the left ventricle after large myocardial infarction – assessment with cardiac magnetic resonance imaging
by: Daniel Sürder, et al.
Published: (2015-06-01)

The Epidemiology of Myeloproliferative Neoplasms in New Zealand between 2010 and 2017: Insights from the New Zealand Cancer Registry
by: Chris Varghese, et al.
Published: (2021-04-01)

Reperfusion therapy for acute myocardial infarction /
by: Bates, Eric R.
Published: (2008)

Risk Factors and Outcomes of Acute Myocardial Infarction in a Cohort of Antiphospholipid Syndrome
by: Yuzhou Gan, et al.
Published: (2022-07-01)

A System-Wide Investigation and Stratification of the Hemostatic Proteome in Premature Myocardial Infarction
by: Joanne L. Dunster, et al.
Published: (2022-06-01)